These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2552196)

  • 1. [A histological examination of liver fibrosis and tissue prolyl hydroxylase in various liver diseases].
    Okada H
    Nihon Shokakibyo Gakkai Zasshi; 1989 May; 86(5):1079-88. PubMed ID: 2552196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolyl hydroxylase activity in normal and diseased human liver.
    Fuller GC; Nolan JC
    Proc Soc Exp Biol Med; 1976 Jan; 151(1):61-4. PubMed ID: 175374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic prolyl hydroxylase activity in human liver disease.
    McPhie JL
    Hepatogastroenterology; 1980 Aug; 27(4):277-82. PubMed ID: 6259037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic prolyl hydroxylase and collagen synthesis in patients with alcoholic liver disease.
    Mann SW; Fuller GC; Rodil JV; Vidins EI
    Gut; 1979 Oct; 20(10):825-32. PubMed ID: 230128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum markers for hepatic fibrosis in alcoholic liver disease: which is the best marker, type III procollagen, type IV collagen, laminin, tissue inhibitor of metalloproteinase, or prolyl hydroxylase?
    Tsutsumi M; Takase S; Urashima S; Ueshima Y; Kawahara H; Takada A
    Alcohol Clin Exp Res; 1996 Dec; 20(9):1512-7. PubMed ID: 8986196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical significance of the determination of serum immunoreactive prolyl hydroxylase (SIRPH) in hepatic fibrosis].
    Suzuki H; Suzuki M; Okabe K; Uchikoshi T
    Nihon Shokakibyo Gakkai Zasshi; 1987 Jun; 84(6):1265-71. PubMed ID: 2822984
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatic collagen proline hydroxylase activity in alcoholic liver disease.
    Mezey E; Potter JJ; Maddrey WC
    Clin Chim Acta; 1976 May; 68(3):313-20. PubMed ID: 179736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of type III and IV procollagen, prolyl 4-hydroxylase mRNAs in fibrotic human liver].
    Yamada H; Aida T; Taguchi K; Asano G
    Nihon Rinsho; 1993 Feb; 51(2):423-7. PubMed ID: 8385240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prolyl hydroxylase activity in liver specimens in chronic liver diseases (author's transl)].
    Langness U; Clausnitzer H; Verspohl M; Grasedyck K
    Med Klin; 1978 Aug; 73(34):1179-82. PubMed ID: 210365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prolyl hydroxylase activity and collagenase activity in the liver tissue of non-alcoholic chronic liver diseases].
    Miura M
    Nihon Shokakibyo Gakkai Zasshi; 1985 Jun; 82(6):1551-8. PubMed ID: 2997518
    [No Abstract]   [Full Text] [Related]  

  • 11. Collagen biosynthesis enzymes in serum and hepatic tissue in liver disease. I. Prolyl hydroxylase.
    Kuutti-Savolainen ER; Risteli J; Miettinen TA; Kivirikko KI
    Eur J Clin Invest; 1979 Feb; 9(1):89-95. PubMed ID: 222594
    [No Abstract]   [Full Text] [Related]  

  • 12. Type IV collagen and laminin contents of livers from patients with alcoholic liver disease.
    Tsutsumi M; Urashima S; Nakase K; Takase S; Takada A
    Alcohol Alcohol Suppl; 1993; 1A():45-52. PubMed ID: 8141922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic gamma-glutamyl transferase and hepatic fibrosis in patients with alcoholic liver disease.
    Yamauchi M; Kimura K; Kawase H; Watanabe Y; Kitahara T; Ogura K; Fujisawa K; Kameda H
    Enzyme; 1984; 32(2):110-5. PubMed ID: 6149933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological parameters and alcohol abstinence determine long-term prognosis in patients with alcoholic liver disease.
    Lackner C; Spindelboeck W; Haybaeck J; Douschan P; Rainer F; Terracciano L; Haas J; Berghold A; Bataller R; Stauber RE
    J Hepatol; 2017 Mar; 66(3):610-618. PubMed ID: 27894795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum lysyl oxidase activity in chronic liver disease in comparison with serum levels of prolyl hydroxylase and laminin.
    Murawaki Y; Kusakabe Y; Hirayama C
    Hepatology; 1991 Dec; 14(6):1167-73. PubMed ID: 1683640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum immunoreactive prolyl hydroxylase in liver disease.
    Tuderman L; Risteli J; Miettinen TA; Kivirikko KI
    Eur J Clin Invest; 1977 Dec; 7(6):537-41. PubMed ID: 204493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic peptidyl prolyl hydroxylase activity and liver fibrosis--a prospective study of 94 infants and children with hepatobiliary disorders.
    Trivedi P; Tanner MS; Portmann B; McClement J; Mowat AP
    Hepatology; 1984; 4(3):436-41. PubMed ID: 6327486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver protocollagen proline hydroxylase in human liver diseases and experimental liver fibrosis.
    Tsujii T; Kimura K; Fukuhara M; Morita T; Matsui T
    Gastroenterol Jpn; 1977; 12(1):21-7. PubMed ID: 193757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic collagen proline hydroxylase activity in alcoholic hepatitis: effect of d-penicillamine.
    Mezey E; Potter JJ; Iber FL; Maddrey WC
    J Lab Clin Med; 1979 Jan; 93(1):92-100. PubMed ID: 215682
    [No Abstract]   [Full Text] [Related]  

  • 20. Is serum prolyl 4-hydroxylase useful as noninvasive marker of liver fibrosis in patients with biliary atresia?
    Kobayashi H; Tamura T; Yamataka A; Lane GJ; Miyano T
    J Pediatr Surg; 2005 Aug; 40(8):1366-7. PubMed ID: 16080952
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.